NCT04443010: Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 226 planned
- Started
- 20 Jan 2021
- Primary completion
- Oct 2026
- Arms
- Phase 1 part: Dose Finding, Phase 2 part: Signal Seeking, Phase IIb part: Activity Evaluation_treatment arm
- Results
- None posted
- 23 Jun 2020: Trial registered
- 20 Jan 2021: Trial started